Physician profile
William B Hall
NPI 1003031691
$20,615.46
in general payments reported to CMS, 2019-2025
22 companies · $50.62 in 2025
The $50.62 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $157 · 2021: $2,584 · 2022: $7,498 · 2023: $6,550 · 2024: $3,342 · 2025: $50.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,290 · Education: $2,605 · Travel and Lodging: $581 · Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,290.00 |
| Education | $2,605.11 |
| Travel and Lodging | $580.85 |
| Food and Beverage | $466.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15,936.22 | 2021-2023 | Illumisite |
| Intuitive Surgical, INC. | $3,303.77 | 2022-2025 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $304.46 | 2019-2024 | Arexvy, Trelegy Ellipta, Nucala |
| Merz North America, INC. | $287.26 | 2019-2022 | |
| Philips North America LLC | $160.40 | 2019-2023 | |
| Galvanize Therapeutics, INC | $104.93 | 2024 | Aliya System |
| Astrazeneca Pharmaceuticals LP | $95.19 | 2019-2024 | Breztri, Tezspire |
| Insmed, INC. | $52.96 | 2020-2025 | Arikayce |
| United Therapeutics Corporation | $47.45 | 2021-2023 | |
| Inogen, INC. | $46.34 | 2022-2024 | |
| Genentech USA, INC. | $39.30 | 2019 | |
| Covidien LP | $37.53 | 2020 | |
| Ethicon INC. | $35.04 | 2022 | |
| Csl Behring | $28.00 | 2019 | |
| Mallinckrodt Hospital Products INC. | $23.35 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $21.03 | 2020 | |
| Paratek Pharmaceuticals, INC. | $20.56 | 2022 | |
| Advanced Respiratory, INC | $18.16 | 2019 | |
| Nabriva Therapeutics, Plc | $16.10 | 2020 | |
| Electromed, INC. | $12.85 | 2021 | |
| Mylan Specialty L.P. | $12.74 | 2021 | |
| Infobionic, INC | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.